Serial Number
86383746
Owner
Adare Pharmaceuticals USA, Inc.Attorney
C. Blair BarbieriFirst Use Date
Aug 15, 2014
Filing Date
Sep 3, 2014
OPTIMµM Trademark
Serial Number: 86383746 • Registration: 4802411
Trademark Classes
Owner Contact Info
7722 Dungan Road
Philadelphia, PA 19111
Entity Type: 03
Legal Representation
Correspondence Address
C. Blair Barbieri HOVEY WILLIAMS LLP
10801 Mastin Blvd., Suite 1000
OVERLAND PARK, KS 66210-1697
United States
Trademark Details
Filing Date
September 3, 2014
Registration Date
September 1, 2015
First Use Anywhere
August 15, 2014
First Use in Commerce
August 15, 2014
Published for Opposition
June 16, 2015
Goods & Services
Manufacturing services for others in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, taste masked release, and delayed release systems, clinical manufacturing of drug formulations for others to support clinical trials, fabrication and preparation of active pharmaceutical ingredients for others, technology scale-up services for others, and integration of technology into manufacturing processes for others, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for oral delivery
Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development services, namely, research and development in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, taste masked release, and delayed release systems, consisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredients, analytic techniques to test drug formulations, analytic services to detect, identify and quantify drug components, stability testing, physical characterization of drug formulations, in-vitro release testing, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for oral delivery
